The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

Minovia’s lead product is MNV-201, an autologous hematopoietic stem cell product that is enriched with allogeneic ...

On day one of the highly anticipated first meeting of the CDC's newly formed vaccine advisory committee, members debated the ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for ...

Without providing further context, HHS Secretary Robert F. Kennedy Jr. says that Gavi needs to “start taking vaccine safety ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Susan Monarez, already acting director of the CDC, said during her confirmation hearing that she sees no causal link between ...

Jefferies analysts called the proxy filing, which is a standard disclosure after a merger agreement, “much more intriguing ...